Series B Life Science Companies

NextPoint Therapeutics is a clinical-stage biotechnology company that develops therapeutics to treat cancer patients.

Sudo Biosciences is a biopharma company that designs and develops medicines that target the tyrosine kinase 2 (TYK2) pseudokinase domain.

Proniras focuses on development of a new parenteral medical countermeasure (MCM) to treat seizures and brain injury.

Cellanome engages in cutting-edge synthetic biology and informatics methods through its multi-omics platform.

STALICLA is a biotechnology company developing precision medicine treatments for patients with neurodevelopmental disorders.

Human Immunology Biosciences is a biotechnology company that focuses on developing therapies for immune-mediated diseases.

Lassen Therapeutics develops antibody biotherapeutics to help improve the lives of patients suffering from serious diseases.

Walden Biosciences is a biotechnology company focused on transforming the treatment of kidney disease.

Evozyne is a generative AI company that focuses on therapeutic discovery and drug development.

Acesion Pharma is a developer of medical drugs designed for the treatment of atrial fibrillation.

Tentarix creates innovative protein therapeutics with uniquely combined bioactivities that leverage synthetic biology.

Cell Microsystems develops, manufactures, and markets innovative products for single-cell biology.

BioFlyte is a biodefense company that commercializes a new class of fieldable biological threat collection.

Kyverna Therapeutics is pioneering a new class of therapies and cures for serious autoimmune diseases.

SURGE Therapeutics seeks to dramatically improve cancer patient survival by disrupting cancer immunotherapy is deployed.

Causaly develops a biomedical research discovery tool designed to find and unlock key hidden evidence in biomedicine.

AgNovos is a regenerative technology that restores the structure and biomechanics of bone to transform the paradigm of care for osteoporosis

OMass Therapeutics is a drug discovery company exploiting novel mass spectrometry platforms to develop therapeutics.

Polymateria is a startup advancing science to help nature deal with plastic pollution.

Abdera is an oncology company developing targeted alpha therapies (TATs) for patients with relapsed, refractory, and metastatic cancers.

Stämm is transforming biomanufacturing with nature-inspired, scalable, and sustainable solutions.

Profility offers support and training, process analysis, and software support description services, including requirements analysis.

Flare Therapeutics is a biotech startup that creates precision therapies for cancer and other disorders by targeting transcription factors.

Empirico is a developer of an insights platform designed to turn biological insights from human genetics into new medicines.

Evonetix is a provider of a desktop platform designed to synthesize DNA at unprecedented accuracy and scale.